In contrast to the usefulness of thyroid transcription factor-1 (TTF-1) in distinguishing primary
adenocarcinoma of the lung from metastatic lesions, TTF-1 expression in pulmonary
squamous cell carcinoma is reported to be at low level and not a suitable immunohistochemical marker. We hypothesized that the highly sensitive detection system,
CSA-II, can visualize even faint expression of TTF-1 in pulmonary
squamous cell carcinoma. In this study, 2 commercially available clones of TTF-1
monoclonal antibody, 8G7G3/1 and SPT24, were used for staining 38 cases of pulmonary
squamous cell carcinoma, in combination with the
CSA-II and the conventional detection system, EnVision. The combined use of the 8G7G3/1 clone with EnVision and
CSA-II showed a positive reaction in only 1 and 4 cases, respectively. The use of SPT24 clone showed positive staining in 5 cases with EnVision and in 20 of 38 cases (52.6%) with the
CSA-II. Interestingly, positive staining by the SPT24-CSA-II technique of samples from tissue blocks preserved for <2 years was 73.6% compared with only 31.5% in those preserved for >2 years. In addition, a 6-month preservation of the cut sections resulted in
stain fading and decreased positivity (50%), compared with freshly cut sections. We conclude that the use of the SPT24
monoclonal antibody with the
CSA-II system can detect even weak expression of TTF-1 in pulmonary
squamous cell carcinoma. This staining technique can potentially allow the discrimination of primary
squamous cell carcinoma of the lung from metastatic lesions, especially in freshly prepared
paraffin sections.